32
Participants
Start Date
December 31, 2008
Primary Completion Date
September 30, 2011
Study Completion Date
December 31, 2011
Ranibizumab
Ranibizumab 0.5 mgs. (0.05 mls.) intravitreally for 6 months then as needed prn for 6 months.
Ivey Eye Institute, London
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER